secwatch / observer
8-K filed April 16, 2025, 7:59 PM ET ticker LONA CIK 0001620463
other material confidence high sentiment negative materiality 0.80

LeonaBio, Inc. (LONA): Nasdaq/NYSE listing notice — Athira Pharma transfers to Nasdaq Capital Market; must regain $1 bid price by Oct 13, 2025

LeonaBio, Inc.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

LeonaBio, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1), 5810(c)(3)(A)).

Exchange
nasdaq
Notice
deficiency notice
Deficiency
minimum bid price
Rules
5450(a)(1), 5810(c)(3)(A)
Exact text from the filing
October 16, 2024 notifying the Company that, based on the closing bid price of the Company’s Common Stock, for the preceding 30 consecutive business days, the Company was not in compliance with the minimum bid price requirement for continued listing on The Nasdaq Global Select Market. Nasdaq Listing Rule 5450(a)(1) requires listed securities to maintain a minimum bid price of $1.00 per share (the “Minimum Bid Price Requirement”). Pursuant to Nasdaq Listing Rule 5810(c)(3)(A), the Company had an initial compliance period of 180 calendar days, or until April 14, 2025, to regain compliance with t
View on SEC.gov

Browse all listing & compliance notices →

LeonaBio, Inc. filing history →

Source: SEC EDGAR
accession 0000950170-25-054707
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.